1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Qualigen Therapeutics Inc (QLGN)
  7. News

QLGN

Qualigen Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Qualigen Therapeutics Inc QLGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.17 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.17 1.17 1.1966 1.17 1.17
more quote information »

Recent News

Date Time Source Heading
9/15/202107:30GLOBEQualigen to Present at the Oppenheimer Fall Healthcare Life..
9/08/202107:30GLOBEQualigen to Present at the H.C. Wainwright 23rd Annual..
8/17/202111:03SEEKVirpax Pharmaceuticals, Sesen Bio leads healthcare gainers;..
8/17/202108:00GLOBEQualigen Therapeutics, Inc. Provides Update on Product..
8/16/202116:22EDGARQuarterly Report (10-q)
8/13/202116:06EDGARCurrent Report Filing (8-k)
7/14/202107:39SEEKQualigen Therapeutics jumps 7% after filing IND application..
7/14/202107:30GLOBEQualigen Therapeutics, Inc. Announces Submission of..
6/08/202107:30GLOBEQualigen Therapeutics Announces Inclusion in Russell..
6/02/202107:30GLOBEQualigen Therapeutics, Inc. to Present at the LD Micro..
5/19/202107:30GLOBEQualigen Therapeutics, Inc. Appoints Tariq Arshad, MD, MBA..
5/18/202106:15EDGARStatement of Changes in Beneficial Ownership (4)
5/17/202117:22EDGARCurrent Report Filing (8-k)
5/17/202116:26EDGARInitial Statement of Beneficial Ownership (3)
5/14/202116:11SEEKQualigen Therapeutics EPS beats by $0.01, beats on revenue
5/14/202113:35GLOBEQualigen Therapeutics, Inc. Reports First Quarter 2021..
5/14/202113:03EDGARQuarterly Report (10-q)
4/29/202115:17EDGARProxy Statement (definitive) (def 14a)
4/26/202118:17EDGARStatement of Changes in Beneficial Ownership (4)
4/21/202115:19EDGARStatement of Changes in Beneficial Ownership (4)
4/09/202117:02SEEKQualigen pulls marketing application for COVID-19 test..
4/09/202116:10EDGARCurrent Report Filing (8-k)
3/31/202116:34EDGARAnnual Transition Report (10-kt)
3/18/202108:30GLOBEQualigen Therapeutics, Inc. to present at the Benzinga..
3/09/202108:30GLOBEQualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief..
3/08/202108:30GLOBEQualigen Therapeutics, Inc. to present at the Oppenheimer..
3/05/202109:16EDGARCurrent Report Filing (8-k)
3/01/202108:30GLOBEQualigen Therapeutics Secures Option to Negotiate License..
1/26/202109:00PRNUSQualigen Therapeutics Announces Completion of Milestone..
1/06/202116:19EDGARCurrent Report Filing (8-k)
1/05/202109:00PRNUSQualigen Therapeutics to Present at the H.C. Wainwright..
12/30/202006:06EDGARStatement of Changes in Beneficial Ownership (4)
12/29/202016:45EDGARStatement of Changes in Beneficial Ownership (4)
12/22/202009:00PRNUSQualigen Therapeutics Issues CEO Letter to Stockholders with..
12/18/202015:55EDGARCurrent Report Filing (8-k)
12/18/202015:07PRNUSQualigen Therapeutics, Inc. Announces Closing of $12 Million..
12/16/202010:25PRNUSQualigen Therapeutics, Inc. Announces $12 Million Registered..
12/15/202009:00PRNUSQualigen Therapeutics Announces Issuance of U.S. Patent for..
12/08/202009:30EDGARCurrent Report Filing (8-k)
12/08/202009:00PRNUSQualigen Therapeutics Announces Board Member Amy Broidrick..
12/07/202016:32EDGARInitial Statement of Beneficial Ownership (3)
12/02/202009:00PRNUSQualigen Therapeutics Completes Recertification of Existing..
11/13/202009:00PRNUSQualigen Therapeutics Issues CEO Letter to Stockholders,..
11/12/202017:15EDGARQuarterly Report (10-q)
11/05/202009:00PRNUSQualigen Therapeutics Engages STA Pharmaceutical as GMP..
11/03/202016:16EDGARCurrent Report Filing (8-k)
10/28/202009:00PRNUSQualigen Therapeutics Receives Positive Pre-IND Response..
See more news about this stock »


Your Recent History
NASDAQ
QLGN
Qualigen T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.